Suppr超能文献

苯基汞和氯化汞的比较肾脏毒理学

The comparative renotoxicology of phenylmercury and mercuric chloride.

作者信息

Magos L, Sparrow S, Snowden R

出版信息

Arch Toxicol. 1982 Jul;50(2):133-9. doi: 10.1007/BF00373395.

Abstract

The acute renotoxicity of HgCl2 and phenylmercuric acetate (PhHgAc) was compared at two intraperitoneal dose levels: 0.5 and 1.0 mg Hg/kg. There was no difference in the type of proximal tubular damage caused by the two mercurials, but 1.0 mg Hg/kg as PhHgAc produced approximately the same degree of damage as 0.5 mg Hg/kg as HgCl2. At the selected dose levels only HgCl2, but not PhHgAc increased the urinary excretion of alkaline phosphatase. At 12 and 24 h after PhHgAc the content of mercury was higher in blood and lower in the kidneys and urine than after the administration of equimolar doses of HgCl2. As the difference in the rectal mercury contents of HgCl2 and PhHgAc treated groups declined with time, difference in renotoxicity seems to relate only to renal mercury taken up within 24 h of administration. It is suggested that the slower renal extraction of mercury - as in regenerating kidneys (Tandon and Magos 1980) - was responsible for the lower degree of renotoxicity in phenylmercury treated rats.

摘要

在两个腹腔注射剂量水平(0.5和1.0毫克汞/千克)下比较了氯化汞(HgCl2)和醋酸苯汞(PhHgAc)的急性肾毒性。两种汞化合物引起的近端肾小管损伤类型没有差异,但1.0毫克汞/千克的醋酸苯汞产生的损伤程度与0.5毫克汞/千克的氯化汞大致相同。在选定的剂量水平下,只有氯化汞而不是醋酸苯汞会增加碱性磷酸酶的尿排泄量。在给予醋酸苯汞后12小时和24小时,血液中的汞含量高于给予等摩尔剂量氯化汞后的含量,而肾脏和尿液中的汞含量则低于后者。随着时间的推移,氯化汞和醋酸苯汞处理组直肠汞含量的差异逐渐减小,肾毒性差异似乎仅与给药后24小时内肾脏摄取的汞有关。有人提出,汞在肾脏中的摄取较慢——如同在再生肾脏中那样(坦登和马戈斯,1980年)——是醋酸苯汞处理大鼠肾毒性较低的原因。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验